Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Activin Receptors, Type I | 1 | 2024 | 36 | 0.910 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 611 | 0.810 |
Why?
|
| Small Molecule Libraries | 4 | 2024 | 139 | 0.630 |
Why?
|
| Macrocyclic Compounds | 1 | 2015 | 12 | 0.470 |
Why?
|
| Furans | 1 | 2015 | 29 | 0.460 |
Why?
|
| Ketones | 1 | 2015 | 29 | 0.460 |
Why?
|
| Drug Discovery | 2 | 2024 | 182 | 0.370 |
Why?
|
| Activin Receptors, Type II | 1 | 2024 | 33 | 0.230 |
Why?
|
| Contraceptive Agents, Male | 1 | 2024 | 32 | 0.220 |
Why?
|
| Contraception | 1 | 2024 | 60 | 0.210 |
Why?
|
| Molecular Structure | 4 | 2021 | 318 | 0.210 |
Why?
|
| Gold | 1 | 2023 | 57 | 0.200 |
Why?
|
| Metal Nanoparticles | 1 | 2023 | 59 | 0.200 |
Why?
|
| Rotaxanes | 1 | 2021 | 1 | 0.190 |
Why?
|
| Calixarenes | 1 | 2021 | 1 | 0.190 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2021 | 35 | 0.190 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 100 | 0.180 |
Why?
|
| Biofilms | 1 | 2021 | 93 | 0.170 |
Why?
|
| Brucella abortus | 1 | 2019 | 5 | 0.160 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 177 | 0.160 |
Why?
|
| DNA | 1 | 2024 | 1674 | 0.150 |
Why?
|
| Structure-Activity Relationship | 4 | 2024 | 611 | 0.150 |
Why?
|
| Stereoisomerism | 2 | 2015 | 118 | 0.140 |
Why?
|
| Tubulin | 2 | 2014 | 76 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2019 | 271 | 0.140 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2017 | 14 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 267 | 0.140 |
Why?
|
| Mitochondrial Membranes | 1 | 2017 | 31 | 0.140 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2017 | 73 | 0.130 |
Why?
|
| DNA Damage | 1 | 2019 | 546 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 167 | 0.120 |
Why?
|
| Cyclization | 1 | 2015 | 17 | 0.120 |
Why?
|
| Macrophages | 1 | 2019 | 704 | 0.120 |
Why?
|
| Ethers, Cyclic | 1 | 2014 | 15 | 0.120 |
Why?
|
| Epothilones | 1 | 2014 | 3 | 0.120 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 11 | 0.120 |
Why?
|
| Aldehydes | 1 | 2015 | 32 | 0.120 |
Why?
|
| Macrolides | 1 | 2014 | 30 | 0.110 |
Why?
|
| Sirolimus | 1 | 2015 | 253 | 0.100 |
Why?
|
| Biological Products | 1 | 2014 | 137 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2024 | 4899 | 0.090 |
Why?
|
| Apoptosis | 1 | 2017 | 1930 | 0.080 |
Why?
|
| Proteins | 1 | 2014 | 1087 | 0.070 |
Why?
|
| Binding Sites | 2 | 2022 | 1370 | 0.070 |
Why?
|
| Blood-Testis Barrier | 1 | 2024 | 12 | 0.060 |
Why?
|
| Protein Binding | 2 | 2022 | 1832 | 0.060 |
Why?
|
| Humans | 8 | 2024 | 133935 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2023 | 38 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2021 | 3167 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2023 | 76 | 0.050 |
Why?
|
| Animals | 6 | 2024 | 36387 | 0.050 |
Why?
|
| Sialic Acids | 1 | 2022 | 20 | 0.050 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2022 | 28 | 0.050 |
Why?
|
| Testis | 1 | 2024 | 426 | 0.050 |
Why?
|
| Polyelectrolytes | 1 | 2021 | 1 | 0.050 |
Why?
|
| Ligands | 1 | 2023 | 572 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2021 | 110 | 0.050 |
Why?
|
| Hemolysis | 1 | 2021 | 113 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2021 | 164 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 204 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 644 | 0.040 |
Why?
|
| Alkylation | 1 | 2019 | 10 | 0.040 |
Why?
|
| Vacuoles | 1 | 2019 | 31 | 0.040 |
Why?
|
| Brucellosis | 1 | 2019 | 20 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 45 | 0.040 |
Why?
|
| Mice | 3 | 2024 | 18909 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 828 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2021 | 1132 | 0.040 |
Why?
|
| Virus Replication | 1 | 2021 | 638 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2023 | 1002 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1735 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 62 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 131 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 143 | 0.030 |
Why?
|
| Liposomes | 1 | 2017 | 207 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2017 | 206 | 0.030 |
Why?
|
| DNA Repair | 1 | 2019 | 630 | 0.030 |
Why?
|
| Amino Alcohols | 1 | 2015 | 2 | 0.030 |
Why?
|
| Pipecolic Acids | 1 | 2015 | 8 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2017 | 781 | 0.030 |
Why?
|
| Pyrans | 1 | 2015 | 10 | 0.030 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 38 | 0.030 |
Why?
|
| 14-3-3 Proteins | 1 | 2014 | 56 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 3751 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 183 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 1438 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 168 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2019 | 1143 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 2035 | 0.020 |
Why?
|
| Male | 2 | 2024 | 65904 | 0.010 |
Why?
|
| Female | 1 | 2017 | 71684 | 0.010 |
Why?
|